Matches in Wikidata for { <http://www.wikidata.org/entity/Q91776429> ?p ?o ?g. }
- Q91776429 description "artículu científicu espublizáu n'avientu de 2019" @default.
- Q91776429 description "scientific article published on 04 December 2019" @default.
- Q91776429 description "wetenschappelijk artikel" @default.
- Q91776429 description "наукова стаття, опублікована 4 грудня 2019" @default.
- Q91776429 name "Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1-2 trial" @default.
- Q91776429 name "Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1-2 trial" @default.
- Q91776429 type Item @default.
- Q91776429 label "Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1-2 trial" @default.
- Q91776429 label "Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1-2 trial" @default.
- Q91776429 prefLabel "Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1-2 trial" @default.
- Q91776429 prefLabel "Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1-2 trial" @default.
- Q91776429 P1433 Q91776429-609F8FFD-658B-4A2A-8071-113E52F093AE @default.
- Q91776429 P1476 Q91776429-7AD43B3E-9FB4-401B-84E4-A1E9BDDD19EA @default.
- Q91776429 P2093 Q91776429-08E9BBFB-0605-439E-A7BD-3E81E3C89BD8 @default.
- Q91776429 P2093 Q91776429-0D95D0B7-11F8-4832-BE33-B9318977A7A5 @default.
- Q91776429 P2093 Q91776429-17DD26F1-BD7A-4F42-B2A2-C5EFBB307DF0 @default.
- Q91776429 P2093 Q91776429-33CA09DD-A244-4EE1-AE8B-FE801761DD38 @default.
- Q91776429 P2093 Q91776429-3C4D7512-55B2-4C9B-A599-11328B9E6468 @default.
- Q91776429 P2093 Q91776429-43FD5538-F2EB-4EAB-BCA5-9CC0BF5E3701 @default.
- Q91776429 P2093 Q91776429-4DAC67B8-2C6F-49C7-BE1B-00D3458E1147 @default.
- Q91776429 P2093 Q91776429-6D9F5393-5699-4916-A871-51761B9078A6 @default.
- Q91776429 P2093 Q91776429-89BDB821-0BD9-486D-AA43-D44BE7F407D0 @default.
- Q91776429 P2093 Q91776429-8C47E317-B076-4EE7-A056-990E9F3CA3B4 @default.
- Q91776429 P2093 Q91776429-8DA45602-2AD8-43A5-BDB5-0FFFF590F58F @default.
- Q91776429 P2093 Q91776429-90D5804D-1588-4B8D-BF94-AD81B40200FA @default.
- Q91776429 P2093 Q91776429-97A570DC-BB95-4766-A197-EBFCA5D39731 @default.
- Q91776429 P2093 Q91776429-A4C29C1E-8539-4162-8614-AFDFF7C4E553 @default.
- Q91776429 P2093 Q91776429-B832EAC1-4438-4BEA-9E9F-8A98DF05FD2D @default.
- Q91776429 P2093 Q91776429-C1092041-2E53-4635-A6AF-F2934C0F07A1 @default.
- Q91776429 P2093 Q91776429-C6480937-5556-4DCC-93EC-9C3F4A3D9E08 @default.
- Q91776429 P2093 Q91776429-F0167F2B-4CA0-4D13-A579-026E507E044B @default.
- Q91776429 P2093 Q91776429-F52CE70C-3AF4-46BD-8077-28F940A0A70C @default.
- Q91776429 P2860 Q91776429-037195D2-4E7B-4587-A4E4-77E993931694 @default.
- Q91776429 P2860 Q91776429-175A41A9-B044-4495-ABA4-3E2F1ADF25DF @default.
- Q91776429 P2860 Q91776429-2D3E136D-F181-4EEA-92DB-07CDA2C228B5 @default.
- Q91776429 P2860 Q91776429-2F4AF1B3-374F-4BA1-8958-B5057C79E398 @default.
- Q91776429 P2860 Q91776429-347CBA69-1803-42D5-A651-BE0FF6E6DBA0 @default.
- Q91776429 P2860 Q91776429-3AF59F79-F071-4E1D-AA8E-C6AA802D9050 @default.
- Q91776429 P2860 Q91776429-4550692E-1F63-4E6F-BA46-384F82100FC6 @default.
- Q91776429 P2860 Q91776429-470B5E96-166D-417E-8BDF-FB6CFD19E099 @default.
- Q91776429 P2860 Q91776429-632E47A4-6B3F-470D-A95E-E07090D43DC7 @default.
- Q91776429 P2860 Q91776429-64FF49AB-7DDE-4ED0-B744-6D6033D78DA2 @default.
- Q91776429 P2860 Q91776429-685B7BDD-A664-4307-B111-F1F15194F682 @default.
- Q91776429 P2860 Q91776429-70D42D4C-8BD4-4AAB-A381-89E56F68A23A @default.
- Q91776429 P2860 Q91776429-833897DE-68AE-4787-B517-ECE2995DC849 @default.
- Q91776429 P2860 Q91776429-87FB2114-7C3E-4D58-9B56-02269E76F70B @default.
- Q91776429 P2860 Q91776429-94485074-A104-490C-BDF7-3C0151696E14 @default.
- Q91776429 P2860 Q91776429-9E0C0E01-F338-4B37-A5CD-57D756496E7F @default.
- Q91776429 P2860 Q91776429-A46B4F7F-B191-40F5-9DB5-20C3B69BE001 @default.
- Q91776429 P2860 Q91776429-A5E63EC1-5B61-42D2-BE2F-6C0194EE6F16 @default.
- Q91776429 P2860 Q91776429-B1087CD0-7346-46C2-B69D-058180AE6856 @default.
- Q91776429 P2860 Q91776429-B336A9C3-CF63-41A8-B52E-52BC1407BA79 @default.
- Q91776429 P2860 Q91776429-BB595C72-9956-49C5-BBFC-7B1E4D40D51E @default.
- Q91776429 P2860 Q91776429-C8C84334-B0F5-4727-A4E3-20C837EDAB4C @default.
- Q91776429 P2860 Q91776429-D5B1E43D-FEDE-4E1D-AD65-90EFDDE46447 @default.
- Q91776429 P2860 Q91776429-D933BE7A-5F7B-48CE-846B-56D003C7CAD2 @default.
- Q91776429 P2860 Q91776429-E17F846B-D5C0-43C3-98AF-B43186935399 @default.
- Q91776429 P2860 Q91776429-E35E7A8F-E52B-43C8-BAD3-0E113CE86933 @default.
- Q91776429 P2860 Q91776429-E4255746-C7E6-4ACE-973E-831183E49A34 @default.
- Q91776429 P2860 Q91776429-F1351778-CE21-41D2-B776-22635187EF87 @default.
- Q91776429 P2860 Q91776429-FD429190-3CED-4386-BE73-E3A52D74F735 @default.
- Q91776429 P304 Q91776429-C0C8C841-6A97-41C2-843F-854DD3B9200E @default.
- Q91776429 P31 Q91776429-09B91BFD-8C6C-4202-9D43-418FC0F578EF @default.
- Q91776429 P356 Q91776429-1370D05D-C289-4B55-B379-6B60FA839775 @default.
- Q91776429 P433 Q91776429-AC91DA10-3A65-45C1-86A9-B5538691D2E6 @default.
- Q91776429 P478 Q91776429-896CAF46-C1F6-4E27-8382-F18AE033DE98 @default.
- Q91776429 P50 Q91776429-300617D4-1D44-4CC0-B3C8-3E663ACF9018 @default.
- Q91776429 P577 Q91776429-22E990D7-66CF-4BD1-8D13-503706E31EA6 @default.
- Q91776429 P698 Q91776429-FF96E3B3-43B4-4D31-9CBC-591F658F7C29 @default.
- Q91776429 P921 Q91776429-2CF8FAEB-48E6-46A6-AF08-2FB9A9C63619 @default.
- Q91776429 P921 Q91776429-997BD856-CCA7-4BF3-B368-1F9A0FC7C7DB @default.
- Q91776429 P356 S1470-2045(19)30671-0 @default.
- Q91776429 P698 31812554 @default.
- Q91776429 P1433 Q13747613 @default.
- Q91776429 P1476 "Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1-2 trial" @default.
- Q91776429 P2093 "Alberto Pappo" @default.
- Q91776429 P2093 "Antonio S Petrilli" @default.
- Q91776429 P2093 "Birgit Geoerger" @default.
- Q91776429 P2093 "Catherine Vezina" @default.
- Q91776429 P2093 "Elizabeth Fox" @default.
- Q91776429 P2093 "Hyoung Jin Kang" @default.
- Q91776429 P2093 "Jacek Toporski" @default.
- Q91776429 P2093 "Julia Glade-Bender" @default.
- Q91776429 P2093 "Kumudu Pathiraja" @default.
- Q91776429 P2093 "Lynley V Marshall" @default.
- Q91776429 P2093 "Margaret E Macy" @default.
- Q91776429 P2093 "Martin Ebinger" @default.
- Q91776429 P2093 "Michal Yalon-Oren" @default.
- Q91776429 P2093 "Navin Pinto" @default.
- Q91776429 P2093 "Scot Ebbinghaus" @default.
- Q91776429 P2093 "Steven G DuBois" @default.
- Q91776429 P2093 "Susan L Cohn" @default.
- Q91776429 P2093 "Theodore W Laetsch" @default.
- Q91776429 P2093 "Wayne Nicholls" @default.
- Q91776429 P2860 Q27323581 @default.
- Q91776429 P2860 Q27853362 @default.
- Q91776429 P2860 Q28131668 @default.
- Q91776429 P2860 Q33632062 @default.
- Q91776429 P2860 Q34577802 @default.
- Q91776429 P2860 Q35117552 @default.